PECCI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 6.768
AS - Asia 5.728
EU - Europa 4.436
SA - Sud America 756
AF - Africa 170
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 17.879
Nazione #
US - Stati Uniti d'America 6.579
CN - Cina 2.737
SG - Singapore 1.225
IE - Irlanda 985
HK - Hong Kong 652
IT - Italia 564
BR - Brasile 561
DE - Germania 519
FI - Finlandia 506
VN - Vietnam 506
RU - Federazione Russa 445
UA - Ucraina 401
FR - Francia 264
SE - Svezia 259
GB - Regno Unito 228
IN - India 135
CA - Canada 95
AR - Argentina 77
ZA - Sudafrica 69
BD - Bangladesh 65
TR - Turchia 63
NL - Olanda 60
IQ - Iraq 58
JP - Giappone 51
MX - Messico 48
EC - Ecuador 33
BE - Belgio 32
ES - Italia 27
ID - Indonesia 27
PK - Pakistan 27
MA - Marocco 23
PL - Polonia 23
MY - Malesia 21
CO - Colombia 18
SA - Arabia Saudita 18
CZ - Repubblica Ceca 17
VE - Venezuela 17
AT - Austria 16
RO - Romania 16
TN - Tunisia 16
CH - Svizzera 14
PH - Filippine 14
UZ - Uzbekistan 13
AZ - Azerbaigian 12
CL - Cile 12
CR - Costa Rica 12
DZ - Algeria 12
EG - Egitto 12
IR - Iran 12
JO - Giordania 11
PA - Panama 11
PY - Paraguay 11
TH - Thailandia 11
BO - Bolivia 10
KE - Kenya 10
KR - Corea 9
PE - Perù 9
AU - Australia 8
BH - Bahrain 8
MU - Mauritius 8
RS - Serbia 8
UY - Uruguay 8
KG - Kirghizistan 7
SK - Slovacchia (Repubblica Slovacca) 7
AE - Emirati Arabi Uniti 6
JM - Giamaica 6
NZ - Nuova Zelanda 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
HU - Ungheria 5
OM - Oman 5
PS - Palestinian Territory 5
PT - Portogallo 5
DK - Danimarca 4
EU - Europa 4
GR - Grecia 4
KW - Kuwait 4
LB - Libano 4
LT - Lituania 4
MD - Moldavia 4
GE - Georgia 3
HN - Honduras 3
HR - Croazia 3
IL - Israele 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
AL - Albania 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CV - Capo Verde 2
DM - Dominica 2
EE - Estonia 2
GH - Ghana 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
NG - Nigeria 2
TM - Turkmenistan 2
Totale 17.856
Città #
Dublin 981
Chandler 833
San Jose 720
Singapore 660
Hong Kong 638
Jacksonville 570
Dallas 566
Ashburn 556
Nanjing 555
Beijing 448
Boardman 272
Nanchang 217
Munich 208
Princeton 197
Wilmington 197
Ho Chi Minh City 187
Lawrence 180
Changsha 177
Lauterbourg 177
Medford 164
Los Angeles 161
Shenyang 159
Hebei 155
Helsinki 150
Jiaxing 127
Milan 123
Hanoi 121
Ann Arbor 102
New York 102
Pavia 93
Tianjin 92
Buffalo 84
Shanghai 81
Hangzhou 79
Moscow 75
Turku 66
Redondo Beach 64
São Paulo 63
Johannesburg 58
Woodbridge 53
Orem 46
Council Bluffs 42
Tokyo 42
Houston 41
Verona 35
Chennai 34
Montreal 32
Frankfurt am Main 31
Norwalk 31
Guangzhou 29
Seattle 29
Ankara 28
London 28
Santa Clara 28
The Dalles 27
Toronto 27
Brussels 26
Denver 26
Brooklyn 25
Da Nang 24
Chicago 23
Fairfield 23
Nuremberg 23
Phoenix 23
Pune 23
Atlanta 21
Baghdad 21
Mexico City 21
Zhengzhou 21
Biên Hòa 19
Columbus 18
Falkenstein 18
Rome 18
Amsterdam 17
San Francisco 17
Auburn Hills 16
Brasília 16
Falls Church 16
Haiphong 16
Ningbo 16
Warsaw 16
Jinan 15
Manchester 15
Stockholm 15
Boston 14
Rio de Janeiro 13
Secaucus 13
Belo Horizonte 12
Curitiba 12
Des Moines 12
Paris 12
Taizhou 12
Tashkent 12
Timisoara 11
Baku 10
Hải Dương 10
Kuala Lumpur 10
Lahore 10
Mumbai 10
Panama City 10
Totale 11.772
Nome #
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 321
Anemia in patients with Covid-19: pathogenesis and clinical significance 286
MYH9-Related Disorders. 249
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 172
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 163
A qualitative and quantitative cytochemical assay of dihydrofolate reductase in megakariocytes of patients with 5q-syndrome. 158
A case of phagocytic multiple myeloma 156
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 153
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. 149
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 149
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 146
5′UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia 144
A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defect. 140
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 140
Cochlear implantation is safe and effective in patients with MYH9-related disease. 139
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 138
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 137
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 137
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 136
BERNARD SOULIER SYNDROME IN A PATIENT AFFECTED BY KLINEFELTER DISEASE: NOVEL A386G HOMOZYGOUS MUTATION OF GPIB alpha GENE WITH ANOMALOUS BEHAVIOUR 132
Cord blood-derived hematopoietic progenitor cells: in vitro response to hematopoietic growth factors and their recruitment into the S-phase of the cell cycle. 130
A MONOALLELIC LOSS-FUNCTION MUTATION IN THE THROMBOPOIETIN (THPO) GENE IS RESPONSIBLE FOR A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT) 129
3D silk bone marrow model: a promising tool to test efficacy of new biomimetic drugs on platelet production 128
A case of metastatic malignant melanoma with bone marrow involvement. 127
Endogenous fibronectin modulates collagen-dependent spreading and proplatelet formation by human megakaryocytes 127
Chaperone molecules concentrate together with the ubiquitin–proteasome system inside particulate cytoplasmic structures: possible role in metabolism of misfolded proteins 126
Dihydrofolate reductase activity in the erythroblasts of patients with 5q-syndrome. 125
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 123
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact 122
Bone marrow necrosis in acute lymphoblastic leukemia. 121
A A386G biallelic GPIb alpha gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis. 119
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 118
Spectrum of the mutations in Bernard-Soulier syndrome. 117
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 117
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene 117
A therapy-related myelodysplastic syndrome with unusual features in a patient treated for acute promyelocytic leukemia. 116
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 115
Both haploinsufficiency and dominant negative effects are responsible for abnormalities of patiens with MHY9-related disease. 115
Clinical and genetic aspects Bernard-Soulier syndrome: searching for genotype/phenotype correlations. 115
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb{alpha} (Bolzano mutation). 115
A novel mutation in gp1bb reveals the role of the cytoplasmic domain of gpibβ in the pathophysiology of bernard‐soulier syndrome and gpib‐ix complex assembly 115
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 114
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 114
THE D1424N AND R1933X MUTATIONS OF MYH9 CAUSE THROMBOCYTOPENIA THROUGH LOSS OF REGULATION OF PROPLATELET FORMATION BY TYPE I COLLAGEN. 113
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 112
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 111
Inherited thrombocytopenias. The evolving spectrum. 111
Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. 110
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 110
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 107
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 104
The Case. Proteinuria and low platelet count. 103
Application of a diagnostic algorithm to 50 consecutive patients with inherited thrombocytopenias 103
X-linked thrombocytopenia with thalassemia: Clinical and biological features of a second family 103
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia 102
Exome sequencing in 116 patients with inherited thrombocytopenia that remained of unknown origin after systematic phenotype-driven diagnostic workup 101
Lessons in platelet production from inherited thrombocytopenias. 101
Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines. 101
MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype. 100
Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. 99
Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim 99
BERNARD SOULIER SYNDROME IN A PATIENT AFFECTED BY KLINEFELTER DISEASE: NOVEL A386G HOMOZYGOUS MUTATION OF GPIB alpha GENE WITH ANOMALOUS BEHAVIOUR 98
Eltrombopag for the treatment of inherited thrombocytopenias: A phase II clinical trial 98
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 97
Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells. 97
NOVEL RUNX1 MUTATIONS IN FAMILIES WITH INHERITED THROMBOCYTOPENIA 97
The D1424N and R1933X mutations of MYH9 result in an altered proplatelet formation by human megakaryocytes 96
Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) 96
Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutation. 96
Dysregulation of oncogenic factors by GFI1B p32: investigation of a novel GFI1B germline mutation 95
Expression, activation, and subcellular localization of the Rap1, GTPase in human cord blood-derived megakaryocytes 94
R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17. 93
Expression, activation, and subcellular localization of the Rap1, GTPase in human cord blood-derived megakaryocytes. 93
Dihydrofolate reductase activity in the erythroblasts of patients with 5q- syndrome. 93
Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) 93
Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia. 93
Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia 93
ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia 93
Expression of dipeptidylaminopeptidase IV/CD26 in peripheral blood lymphocytes of hemophilic subjects. 92
ETV6-RELATED THROMBOCYTOPENIA (ETV6-RT): CLINICAL AND PATHOGENETIC CHARACTERIZATION OF AN INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 92
Cord blood in vitro expanded CD41+ cells: Identification novel components of megakaryocytopoiesis 91
Expression, activation and subcellular localization of the Rap1 GTPase in human cord blood-derived megakaryocytes 90
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia 90
ANKRD26-related thrombocytopenia and myeloid malignancies 90
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 90
Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrow. 89
Low-dose thalidomide ameliorates cytopenia and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II clinical trial. 89
Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 89
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 89
The european hematology association roadmap for european hematology research: A consensus document 89
Expression, activation, and subcellular localization of the Rap1 GTPase in cord blood-derived human megakaryocytes. 88
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. 88
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. 88
Expression of p53, bcl-2 and ras oncoproteins in acute leukemias and myelodysplastic syndromes 88
Severe to profound deafness may be associated with MYH9-related disease: Report of 4 patients 88
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 86
Dissecting clinical findings: platelet defects segregate independently of deafness and cataract in a family affected by an apparent syndromic form of macrothrombocytopenia. 86
Application of a Diagnostic Algorithm for Inherited Thrombocytopenia Patients in the Setting of a Developing Country. 85
Gene expression profiling of megakaryocytes from human cord blood. 85
Von Willebrand Factor and GPIb regulates proplatelets formation by human megakaryocytes. 84
Totale 11.561
Categoria #
all - tutte 75.148
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.148


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021273 0 0 0 0 0 0 0 0 0 126 116 31
2021/2022866 15 1 21 14 38 29 26 47 49 39 122 465
2022/20232.484 265 165 14 215 237 250 2 125 1.097 12 67 35
2023/20241.020 96 166 25 81 161 237 55 54 8 50 45 42
2024/20252.960 70 235 77 96 68 197 201 238 643 100 341 694
2025/20266.506 498 470 882 841 747 307 1.381 364 608 408 0 0
Totale 18.360